* Company cuts out commercial medical education companies
* Only about 20 accredited providers will get grants
Drugmaker GlaxoSmithKline (GSK.L) said on Monday it will pare back funding for continuing medical education seminars.
While the company did not link its decision to political developments, pressure has been mounting in Congress and among some medical journal editors to limit the drug industry's influence over doctors.
Deirdre Connelly, president of Glaxo's operations in North America, said in a statement that starting in 2010, the company will limit its support for medical education programs, funding only independent programs with "the greatest potential to improve patient health."
The company said it will cut out education programs put on by commercial providers, and will only pay for programs from about 20 medical education providers with a track record of quality.
READ MORE @ REUTERS